Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation

European Journal of Immunology
Nobuko IshiuraManabu Fujimoto

Abstract

CD19 is a B-cell transmembrane molecule that is critical for B-cell activation. CD19 serves as a scaffold protein for key signal transduction molecules including Lyn, PI3K, and Vav, by providing docking sites for these molecules via phosphorylation of CD19-Y(513), CD19-Y(482), and CD19-Y(391). We investigated the process of CD19 tyrosine phophorylation during B-cell activation using Ab specific for each of these phosphorylated tyrosines. BCR engagement induced differential tyrosine phosphorylation, as CD19-Y(513) phophorylation occurred first, and CD19-Y(482) phosphorylation was delayed and transient. Different BCR isotypes exhibited distinct patterns of CD19 phosphorylation: IgG-BCR ligation resulted in faster phosphorylation of CD19-Y(513) and more intense phosphorylation of CD19-Y(391) than IgM-BCR ligation. This affected CD19-mediated downstream pathways involving Vav, PI3K, and Akt. Additionally, the phosphorylation profile of CD19 differed distinctly according to its plasma membrane location. CD19 phosphorylated at Y(513) was almost exclusively located within lipid rafts, whereas phosphorylated Y(482) and Y(391) were found both inside and outside of the rafts. Furthermore, the phosphorylation of all three tyrosines was re...Continue Reading

References

Jul 15, 1993·Biochemical and Biophysical Research Communications·C M Roifman, S Ke
Jul 1, 1993·International Immunology·C J van NoeselR A van Lier
Aug 8, 1998·Seminars in Immunology·M FujimotoT F Tedder
Dec 10, 1999·The Journal of Experimental Medicine·P C ChengS K Pierce
Jun 3, 2000·Annual Review of Immunology·D T Fearon, M C Carroll
Oct 24, 2000·The Journal of Biological Chemistry·D C OteroR C Rickert
Dec 20, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P A ZipfelA M Pendergast
May 23, 2001·International Immunopharmacology·M D Zabel, J H Weis
Jan 29, 2002·Nature Immunology·Stephen W Martin, Christopher C Goodnow
May 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manabu FujimotoThomas F Tedder
Oct 22, 2002·Immunity·Yue WangRobert H Carter
Dec 21, 2002·Science·Chisato WakabayashiTakeshi Tsubata
Feb 4, 2003·Nature Immunology·Amy N AnzelonRobert C Rickert
Mar 5, 2003·Annual Review of Immunology·Michelle DykstraSusan K Pierce
Jan 15, 2004·Current Directions in Autoimmunity·Robert H Carter, Robert A Barrington
Jun 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephen R BrooksRobert H Carter
Aug 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elena VigoritoMartin Turner
May 12, 2005·Current Opinion in Immunology·Robert C Rickert
Jan 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manabu FujimotoShinichi Sato
Mar 25, 2006·Nature Reviews. Immunology·John G Monroe
May 5, 2006·The New England Journal of Medicine·Menno C van ZelmJosé L Franco
Mar 18, 2009·Immunological Reviews·Tomohiro Kurosaki, Masaki Hikida

❮ Previous
Next ❯

Citations

Dec 6, 2012·Experimental Hematology & Oncology·Kemeng WangDelong Liu
Sep 14, 2010·Journal of Dermatological Science·Manabu Fujimoto
Aug 24, 2010·Immunological Reviews·Fabienne MackayMargaret L Hibbs
Oct 13, 2016·Oncotarget·Rachel S WeltSydney Welt
May 12, 2020·Frontiers in Immunology·Chiara CaraccioChristian M Schürch
Aug 28, 2020·BioMed Research International·Feng LiYing Li
Aug 21, 2021·Frontiers in Cell and Developmental Biology·Zhou FanLinhu Ge

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.